Xiaomi has announced a stock buyback program worth up to HK$2.5 billion ($321 million) amid rising competition and increasing component costs.

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

The supply issue in the province is under a microscope as the Ministry of Health continues its phased approach to lower the ...

Let’s retire the idea that burnout is merely overwork. Let’s broaden our understanding to include blagony: the strain of ...

Officials in Oceanside and Carlsbad are working on moving hundreds of unsheltered homeless people into housing. So far, it’s ...